Mr. Westermann: From its inception, 22 years ago, the company was involved in imaging. It started by developing software for satellites. At the same time, Medasys became a value-added reseller for Hewlett Packard computers. Today the company is involved in two activities: it provides computer infrastructure and solutions to industry, to services - banking and insurance - and to retail chains, as well as to the healthcare field. In this area, we supply large systems and servers operating under UNIX (IBM AIX and HP-UX) or Linux. And we install the middle-ware that goes with it, to allow the tuning of databases – mostly Oracle -, assure high reliability, ensure security, enable networking and deliver all the services all that make a real computer system work. The other activity, which is complementary to the first one, is the logical continuation of our involvement in imaging- and then later in medical imaging. In this field, we provide a complete set of clinical software for hospitals. By clinical software, I mean laboratory information systems, radiology information systems, picture archiving and communication systems, electronic patient record and all the various computer tools that are necessary to operate them successfully.
TWST: Can you describe the competitive landscape and how you see yourself positioned in the space?
Mr. Westermann: Our Company is positioned in a very particular field, which is clinical medical software. Most hospitals are currently using computer systems essentially for administrative work whereas; we saw the healthcare field as an area of production of care. In every industry, except healthcare, every body talks about production of something; be it a product or a service. Healthcare, because it has got this mythical connotation that is related to everyone of us, seems to be a different world. People speak about cost of care, they speak about quality of care, but nobody really dares say that, after all, a hospital is only a place where you produce care.
For more information call (212) 952 7433. The Wall Street Transcript does not endorse any of the comments made by interviewees, and does not make stock recommendations.